Showing results (441-450 of 500) with videos related to

Sort By:
Pageof 50
The Lancet. Gastroenterology & Hepatology|June 20, 2020
British Society of Gastroenterology endorsed guidance for the management of immune checkpoint inhibitor-induced enterocolitisNick Powell, Hajir Ibraheim, Tim Raine, et al.
Theranostics|August 1, 2022
Erratum: Evaluation of 18F-IAM6067 as a sigma-1 receptor PET tracer for neurodegeneration in vivo in rodents and in human tissue: ErratumFrançois-Xavier Lepelletier, Matthias Vandesquille, Marie-Claude Asselin, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|March 25, 2024
Presentation, management, and outcomes of norovirus in adult and pediatric solid organ and hematopoietic stem cell transplant recipients: A multicenter, retrospective studyMichelle Callegari, Lara A Danziger-Isakov, Anne Rose, et al.
JMIR Research Protocols|May 22, 2026
Determining the Impact of a Physiotherapist-Led Primary Care Model for Hip and Knee Pain: Protocol and Analysis Plan for a Cluster Randomized Controlled Trial With Process EvaluationJordan Miller, Catherine Donnelly, Chad McClintock, et al.
American Journal of Human Genetics|January 13, 2022
The genetic architecture of pediatric cardiomyopathyStephanie M Ware, Surbhi Bhatnagar, Phillip J Dexheimer, et al.
American Heart Journal|June 14, 2023
Cardiac imaging and biomarkers for assessing myocardial fibrosis in children with hypertrophic cardiomyopathySonya Kirmani, Pamela K Woodard, Ling Shi, et al.
BMJ Open|March 8, 2022
CUP study: protocol for a comparative analysis of centralised waitlist effectiveness, policies and innovations for connecting unattached patients to primary care providersEmily Gard Marshall, Mylaine Breton, Michael Green, et al.
British Journal of Haematology|March 29, 2019
Lenalidomide plus rituximab (R2 ) in previously untreated marginal zone lymphoma: subgroup analysis and long-term follow-up of an open-label phase 2 trialMelody R Becnel, Loretta J Nastoupil, Felipe Samaniego, et al.
Internal Medicine Journal|October 28, 2024
Medicine Access Programmes: what do patients think - a patient-reported outcome study on ribociclib in metastatic breast cancer in AustraliaNatasha Yap, Vanessa Wong, Catherine Morton, et al.
Blood Advances|January 11, 2022
Safety and activity of pembrolizumab in combination with rituximab in relapsed or refractory follicular lymphomaLoretta J Nastoupil, Collin K Chin, Jason R Westin, et al.
Pageof 50